# US 2021/0259629 A1 · Therapy scoring for hemodynamic conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0259629 A1
- Document ID: US20210259629A1
- Status: Published application
- Kind: A1
- Application number: 16/985,937
- Filed: 2020-08-05
- Published: 2021-08-26
- Earliest claimed: 2020-02-24
- Assignees: Edwards Lifesciences Corporation
- Applicants: Edwards Lifesciences Corporation
- Inventors: Rachel June Smith; Zhongping Jian; Feras Al Hatib; Andrew Marino; Sai Prasad Buddi
- Web page: https://patentgrep.com/patent/US20210259629A1

## CPC

- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/4848: {Monitoring or testing the effects of treatment, e.g. of medication}
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/02108: {from analysis of pulse wave characteristics}
- A61B 5/02405: {Determining heart rate variability}
- A61B 5/029: Measuring blood output from the heart, e.g. minute volume
- A61B 5/4839: {combined with drug delivery}
- A61B 5/7275: {Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- G16H 40/67: for remote operation
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61B 5/743: {Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

A system for monitoring arterial pressure of a patient determines a score that is predictive of responsiveness of the patient to a therapy. Sensed hemodynamic data representative of an arterial pressure waveform of the patient are received by a hemodynamic monitor. Magnitude data and trend data are derived from the hemodynamic data. The score that is predictive of the responsiveness of the patient to the therapy is determined based on the magnitude data and the trend data of the hemodynamic parameter. A representation of the score is output.

## Claims

### Claim 1

A method for monitoring arterial pressure of a patient and determining a score that is predictive of responsiveness of the patient to a therapy, the method comprising:
receiving, by a hemodynamic monitor, sensed hemodynamic data representative of an arterial pressure waveform of the patient;
deriving, by the hemodynamic monitor from the hemodynamic data, magnitude data and trend data of a hemodynamic parameter;
determining, by the hemodynamic monitor, the score that is predictive of the responsiveness of the patient to the therapy based on the magnitude data and the trend data of the hemodynamic parameter; and
outputting, by the hemodynamic monitor, a representation of the score.

### Claim 2 (depends on 1)

The method of claim 1, wherein determining the score based on the magnitude data and the trend data of the hemodynamic parameter comprises:
determining, based on the magnitude data of the hemodynamic parameter, a magnitude sub-score;
determining, based on the trend data of the hemodynamic parameter, a trend sub-score; and
determining the score as a combination of the magnitude sub-score and the trend sub-score.

### Claim 3 (depends on 2)

The method of claim 2, wherein determining the score as the combination of the magnitude sub-score and the trend sub-score comprises determining the score as a multiplicative product of the magnitude sub-score and the trend sub-score.

### Claim 4 (depends on 2)

The method of claim 2, wherein determining the magnitude sub-score comprises determining the magnitude sub-score as a normalized value ranging between a lower normalized threshold at a lower magnitude threshold of the magnitude data of the hemodynamic parameter and an upper normalized threshold at an upper magnitude threshold of the magnitude data of the hemodynamic parameter.

### Claim 5 (depends on 4)

The method of claim 4, wherein determining the magnitude sub-score as the normalized value comprises interpolating between the lower normalized threshold and the upper normalized threshold in response to determining that the magnitude data of the hemodynamic parameter is greater than the lower magnitude threshold and is less than the upper magnitude threshold.

### Claim 6 (depends on 2)

The method of claim 2, wherein deriving the trend data of the hemodynamic parameter comprises determining a slope of a best-fit line of the hemodynamic parameter associated with a defined time interval.

### Claim 7 (depends on 6)

The method of claim 6, wherein determining the trend sub-score comprises normalizing the slope of the best-fit line to determine a normalized slope of the best-fit line of the hemodynamic parameter associated with the defined time interval.

### Claim 8 (depends on 7)

The method of claim 7, wherein determining the trend sub-score further comprises applying a weighting factor to the normalized slope of the best-fit line to determine a weighted normalized slope of the best-fit line of the hemodynamic parameter associated with the defined time interval.

### Claim 9 (depends on 2)

The method of claim 2, wherein deriving the trend data of the hemodynamic parameter comprises determining a plurality of slopes of a plurality of best-fit lines of the hemodynamic parameter associated with a plurality of defined time intervals.

### Claim 10 (depends on 1)

The method of claim 1, wherein the hemodynamic parameter is one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and wherein the therapy is intravenous delivery of saline fluid to the patient.

### Claim 11 (depends on 10)

The method of claim 10, further comprising:
deriving, by the hemodynamic monitor from the hemodynamic data, magnitude data and trend data of one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI);
determining, by the hemodynamic monitor, a second score that is predictive of responsiveness of the patient to intravenous delivery of a vasopressor based on the magnitude data and the trend data of the one of SVR or SVRI; and
outputting, by the hemodynamic monitor, a representation of the second score.

### Claim 12 (depends on 11)

The method of claim 11, further comprising:
deriving, by the hemodynamic monitor from the hemodynamic data, magnitude data and trend data of one of maximal rate of rise of arterial pressure (dP/dtmax), cardiac output (CO), or cardiac index (CI);
determining, by the hemodynamic monitor, a third score that is predictive of responsiveness of the patient to intravenous delivery of an inotrope based on the magnitude data and the trend data of the one of dP/dtmax, CO, or CI; and
outputting, by the hemodynamic monitor, a representation of the third score.

### Claim 13 (depends on 1)

The method of claim 1, wherein the hemodynamic parameter is one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and wherein the therapy is intravenous delivery of a vasopressor to the patient.

### Claim 14 (depends on 13)

The method of claim 13, further comprising:
deriving, by the hemodynamic monitor from the hemodynamic data, magnitude data and trend data of maximal rate of rise of arterial pressure (dP/dtmax);
determining, by the hemodynamic monitor, a second score that is predictive of responsiveness of the patient to intravenous delivery of an inotrope based on the magnitude data and the trend data of dP/dtmax; and
outputting, by the hemodynamic monitor, a representation of the second score.

### Claim 15 (depends on 1)

The method of claim 1, wherein the hemodynamic parameter is one of maximal rate of rise of arterial pressure (dP/dtmax), cardiac output (CO), or cardiac index (CI), and wherein the therapy is intravenous delivery of an inotrope to the patient.

### Claim 16

A system for monitoring arterial pressure of a patient and determining a score that is predictive of responsiveness of the patient to a therapy, the system comprising:
a hemodynamic sensor that produces hemodynamic data representative of an arterial pressure waveform of the patient;
a system memory that stores hemodynamic therapy scoring software code;
a user interface; and
a hardware processor that is configured to execute the hemodynamic therapy scoring software code to:
derive, from the hemodynamic data representative of the arterial pressure waveform of the patient, magnitude data and trend data of a hemodynamic parameter;
determine the score that is predictive of the responsiveness of the patient to the therapy based on the magnitude data and the trend data of the hemodynamic parameter; and
output, via the user interface, a representation of the score.

### Claim 17 (depends on 16)

The system of claim 16, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the score based on the magnitude data and the trend data of the hemodynamic parameter by:
determining, based on the magnitude data of the hemodynamic parameter, a magnitude sub-score;
determining, based on the trend data of the hemodynamic parameter, a trend sub-score; and
determining the score as a combination of the magnitude sub-score and the trend sub-score.

### Claim 18 (depends on 17)

The system of claim 17, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the score as the combination of the magnitude sub-score and the trend sub-score by determining the score as a multiplicative product of the magnitude sub-score and the trend sub-score.

### Claim 19 (depends on 17)

The system of claim 17, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the magnitude sub-score as a normalized value ranging between a lower normalized threshold at a lower magnitude threshold of the magnitude data of the hemodynamic parameter and an upper normalized threshold at an upper magnitude threshold of the magnitude data of the hemodynamic parameter.

### Claim 20 (depends on 17)

The system of claim 17, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the trend data of the hemodynamic parameter by determining a slope of a best-fit line of the hemodynamic parameter associated with a defined time interval.

### Claim 21 (depends on 20)

The system of claim 20, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the trend sub-score by normalizing the slope of the best-fit line to determine a normalized slope of the best-fit line of the hemodynamic parameter associated with the defined time interval.

### Claim 22 (depends on 21)

The system of claim 21, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to determine the trend sub-score by applying a weighting factor to the normalized slope of the best-fit line to determine a weighted normalized slope of the best-fit line of the hemodynamic parameter associated with the defined time interval.

### Claim 23 (depends on 17)

The system of claim 17, wherein the hardware processor is configured to execute the hemodynamic therapy scoring software code to derive the trend data of the hemodynamic parameter by determining a plurality of slopes of a plurality of best-fit lines of the hemodynamic parameter associated with a plurality of defined time intervals.

### Claim 24 (depends on 16)

The system of claim 16, wherein the hemodynamic parameter is one of stroke volume variation (SVV), pulse pressure variation (PPV), stroke volume (SV), or stroke volume index (SVI), and wherein the therapy is intravenous delivery of saline fluid to the patient.

### Claim 25 (depends on 24)

The system of claim 24, wherein the hardware processor is further configured to execute the hemodynamic therapy scoring software code to:
derive, from the hemodynamic data, magnitude data and trend data of one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI);
determine a second score that is predictive of responsiveness of the patient to intravenous delivery of a vasopressor based on the magnitude data and the trend data of the one of SVR or SVRI; and
output, via the user interface, a representation of the second score.

### Claim 26 (depends on 25)

The system of claim 25, wherein the hardware processor is further configured to execute the hemodynamic therapy scoring software code to:
derive, from the hemodynamic data, magnitude data and trend data of one of maximal rate of rise of arterial pressure (dP/dtmax), cardiac output (CO), or cardiac index (CI);
determine a third score that is predictive of responsiveness of the patient to intravenous delivery of an inotrope based on the magnitude data and the trend data of the one of dP/dtmax, CO, or CI; and
output, via the user interface, a representation of the third score.

### Claim 27 (depends on 16)

The system of claim 16, wherein the hemodynamic parameter is one of systemic vascular resistance (SVR) or systemic vascular resistance index (SVRI), and wherein the therapy is intravenous delivery of a vasopressor to the patient.

### Claim 28 (depends on 27)

The system of claim 27, wherein the hardware processor is further configured to execute the hemodynamic therapy scoring software code to:
derive, from the hemodynamic data, magnitude data and trend data of one of maximal rate of rise of arterial pressure (dP/dtmax), cardiac output (CO), or cardiac index (CI);
determine a second score that is predictive of responsiveness of the patient to intravenous delivery of an inotrope based on the magnitude data and the trend data of the one of dP/dtmax, CO, or CI; and
output, via the user interface, a representation of the second score.

### Claim 29 (depends on 16)

The system of claim 16, wherein the hemodynamic parameter is one of maximal rate of rise of arterial pressure (dP/dtmax), cardiac output (CO), or cardiac index (CI), and wherein the therapy is intravenous delivery of an inotrope to the patient.
